|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate, at cost: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Development costs and construction in progress | ||||||||||||||||||||
| Leasehold improvements and equipment | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Less accumulated depreciation and amortization | ||||||||||||||||||||
| Real estate, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Net investment in lease | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Investments in U.S. Treasury bills | ||||||||||||||||||||
| Tenant and other receivables | ||||||||||||||||||||
| Investments in partially owned entities | ||||||||||||||||||||
| 220 Central Park South condominium units ready for sale | ||||||||||||||||||||
| Receivable arising from the straight-lining of rents | ||||||||||||||||||||
| Deferred leasing costs, net of accumulated amortization of $251,710 and $233,448 | ||||||||||||||||||||
| Identified intangible assets, net of accumulated amortization of $87,096 and $81,962 | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets | ||||||||||||||||||||
| LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY | ||||||||||||||||||||
| Mortgages payable, net | ||||||||||||||||||||
| Senior unsecured notes, net | ||||||||||||||||||||
| Unsecured term loan, net | ||||||||||||||||||||
| Unsecured revolving credit facilities | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Deferred compensation plan | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interests: | ||||||||||||||||||||
| Class A units - 16,572,667 and 16,650,713 units outstanding | ||||||||||||||||||||
| Series D cumulative redeemable preferred units - 141,400 units outstanding | ||||||||||||||||||||
| Partnership Interest | ||||||||||||||||||||
| Subsidiary | ||||||||||||||||||||
| Total redeemable noncontrolling interests | ||||||||||||||||||||
| Preferred shares of beneficial interest: issued shares (in shares) | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred shares of beneficial interest: no par value per share; authorized 110,000,000 shares; issued and outstanding 48,787,338 and 48,788,450 shares | ||||||||||||||||||||
| Common shares of beneficial interest: $0.04 par value per share; authorized 250,000,000 shares; issued and outstanding 186,958,059 and 190,666,367 shares | ||||||||||||||||||||
| Additional capital | ||||||||||||||||||||
| Earnings less than distributions | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders' / partners' equity | ||||||||||||||||||||
| Noncontrolling interests in consolidated subsidiaries | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interests / partnership units and equity | ||||||||||||||||||||
| Outstanding Partnership Units held by Third Parties (shares) | ||||||||||||||||||||
Loading...